Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00555633 |
Recruitment Status
:
Completed
First Posted
: November 8, 2007
Last Update Posted
: September 30, 2009
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease |
---|
Skin Cancer Xeroderma Pigmentosum Basal Cell Nevus Syndrome |
Study Type : | Observational |
Actual Enrollment : | 13 participants |
Official Title: | Regular Use of an SPF30 Sunscreen and an After-sun-lotion in Skin Cancer Risk Patients, Particularly in Xeroderma Pigmentosum and Basal Cell Nevus Syndrome |
Study Start Date : | October 2004 |
Actual Study Completion Date : | February 2006 |

- Number of skin cancers [ Time Frame: retrospective ]
- Patients' skin score parameters (including smoothness, color spots, wrinkles, burning, irritation, teleangiectasia, infections, warts, and skin lesions or sores) [ Time Frame: retrospective ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 19 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Xeroderma pigmentosum
- Basal cell nevus syndrome
- Other patient with a history of multiple skin cancers (three or more lesions, including actinic keratosis, squamous cell carcinoma, basal cell carcinoma, and/or malignant melanoma)
Exclusion Criteria:
- Intolerance of study preparation
- Allergy against study preparation
- Non-acceptable side effects

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00555633
Austria | |
Medical University of Graz, Department of Dermatology | |
Graz, Austria, A-8036 |
Principal Investigator: | Peter Wolf, MD | Medical University of Graz, Austria |
Responsible Party: | Peter Wolf, MD, Principal Investigator, Medical University of Graz, Austria |
ClinicalTrials.gov Identifier: | NCT00555633 History of Changes |
Other Study ID Numbers: |
16-015 ex 04/05 |
First Posted: | November 8, 2007 Key Record Dates |
Last Update Posted: | September 30, 2009 |
Last Verified: | September 2009 |
Keywords provided by Medical University of Graz:
Photoprotection Sunscreen After-sun-lotion DNA repair enzymes |
liposomes skin cancer Xeroderma pigmentosum Basal cell nevus syndrome |
Additional relevant MeSH terms:
Syndrome Skin Neoplasms Basal Cell Nevus Syndrome Xeroderma Pigmentosum Ichthyosis Disease Pathologic Processes Neoplasms by Site Neoplasms Skin Diseases Odontogenic Cysts Jaw Cysts Bone Cysts Cysts Carcinoma, Basal Cell |
Carcinoma Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms, Basal Cell Neoplastic Syndromes, Hereditary Bone Diseases, Developmental Bone Diseases Musculoskeletal Diseases Jaw Diseases Stomatognathic Diseases Abnormalities, Multiple Congenital Abnormalities Genetic Diseases, Inborn Precancerous Conditions Skin Abnormalities |